Transcriptional upregulation of <scp>CXCL13</scp> is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma-Reference-Cited by-同舟云学术

Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma

Published:2022-12 Issue:6 Volume:12 Page:7639-7650
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Park Sehhoon¹,Cha Hongui²³,Kim Hong Sook²,Lee Boram²³^ORCID,Kim Soyeon⁴⁵,Kim Tae Min⁴⁶^ORCID,Jung Hyu Ae¹^ORCID,Sun Jong‐Mu¹,Ahn Jin Seok¹,Ahn Myung‐Ju¹,Park Keunchil¹²^ORCID,Park Woong‐Yang²³,Lee Se‐Hoon¹²^ORCID

Affiliation:

1. Division of Hematology‐Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea

2. Department of Health Science and Technology, Samsung Advanced Institute of Health Science and Technology Sungkyunkwan University Seoul Republic of Korea

3. Samsung Genome Institute Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Republic of Korea

4. Seoul National University Cancer Research Institute Seoul Republic of Korea

5. Biomedical Research Institute, Seoul National University Hospital Seoul Republic of Korea

6. Departments of Internal Medicine Seoul National University Hospital, Seoul National University College of Medicine Seoul Republic of Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5460